Together, Brain Canada and the ALS Society of Canada are pleased to announce the continuation of the Discovery Grant Program. The purpose of this program is to invest in the best possible projects that are focused on identifying causes of, or treatments for ALS and/or related neurological diseases, or research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to persons or families living with ALS.
Evidence clearly shows that increasing equity, diversity and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and ALS Canada are committed to excellence through equity and encourage applicants of diverse backgrounds to apply to our funding opportunities.
The 2022 ALS Canada – Brain Canada Discovery Grant Program consists of two streams that will fund novel and innovative research approaches, supported by sound rationale and a feasible experimental plan:
Stream 1 : Aimed at nurturing novel ideas looking to obtain preliminary data or to pursue ideas supported by very early data signals. Up to six awards of up to $125,000 will be awarded in this cycle.
Stream 2 : Aimed at funding more ambitious projects that are supported with some level of preliminary data to justify the larger investment. Up to two awards of up to $300,000 will be awarded in this cycle.
For both streams, a minimum of 2 independent investigators are required, from different institutions or distinct departments within the same institution. A lead investigator must be named who will assume the administrative and financial responsibilities for the team grant. The lead investigator’s institution will be deemed the host institution for the grant and will receive the funding disbursements from Brain Canada.
Refer here for application details
Call announced | May 12, 2022
Application Deadline | July 5, 2022 (1:00pm ET)
Notification of award | October 2022
Funding begins | January 2023